RT Journal Article
T1 Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass.
A1 Perez-Arana, Gonzalo-Martin
A1 Diaz-Gomez, Alfredo
A1 Camacho-Ramirez, Alonso
A1 Ribelles-Garcia, Antonio
A1 Almorza-Gomar, David
A1 Gracia-Romero, Manuel
A1 Prada-Oliveira, Jose-Arturo
K1 Enterohormones
K1 Glucose transporter
K1 Incretines
K1 Intestinal tube
K1 PYY
K1 Pancreas
K1 Peptide tyrosine-tyrosine
K1 RYGB
K1 Roux-en-Y gastric bypass
K1 Type 2 diabetes mellitus
K1 Área de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
AB PURPOSE : Intestinal remodeling and adaptation of the alimentary limb after Roux-en-Y gastric bypass (RYGB) play an important role in the pathophysiological events that lead to type 2 diabetes mellitus (T2DM) improvement. Intestinal absorptive loop hypertrophy and growth following surgery have been related to GLP-2 secretion by ileal L-cells. The secretion of peptide tyrosine-tyrosine (PYY) enterohormone after a meal has been proposed as a trigger for ileal secretion of GLP-1. Our aim is to determine the role of PYY as a GLP-2 secretion modulator as an adaptation result in the alimentary limb after RYGB. We used a non-obese euglycemic rodent model. Circulating glucose, insulin, PYY, and GLP-2 were measured in the experimental and control groups. We used four groups: fasting control, Sham-operated, RYGB-operated (RYGB), and RYGB-operated and treated with BIIE0246 (RYGB + BII). BIIE0246 is a NPY2 receptor antagonist in L-cells. Intestinal glucose transporters and GLP-1 and PYY gut expression and hypertrophy were analyzed after 12 weeks of surgery. RYGB increased PYY3-36 plasma levels in rats with or without BII treatment. A high-insulin response was observed in the RYGB group but not in the control or RYGB + BII groups. BIIE0246 treatment limited plasma GLP-2 levels. In the alimentary intestinal limb, hypertrophy and SGLT1 and GLUT1 expression appeared to be reduced after RYGB compared to controls. The postprandial ileal PYY secretion is enhanced after RYGB. This increase mediates GLP-2 release through its binding to the Y2 receptor on L-cells. This mechanism plays a role in alimentary limb hypertrophy after surgery.
PB Springer
YR 2022
FD 2022-10-11
LK http://hdl.handle.net/10668/20875
UL http://hdl.handle.net/10668/20875
LA en
NO Pérez-Arana GM, Díaz-Gómez A, Camacho-Ramírez A, Ribelles-García A, Almorza-Gomar D, Gracia-Romero M, et al. Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass. Obes Surg. 2022 Dec;32(12):4023-4032
DS RISalud
RD Apr 6, 2025